Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Line Between Boost and Ban

Bruce N. Cronstein, MD  |  Issue: April 2008  |  April 1, 2008

Bruce N. Cronstein, MD

In 1980, Muhammed Ali, a model sportsman in so many ways, was soundly beaten in a fight with Larry Holmes. Following the fight Ali appeared sluggish and had difficulty speaking and walking. He later admitted that, “I took too many thyroid pills. Always used to double up on my vitamins. Bad idea with thyroid pills. Started training at 253 [pounds], went down to 217 [pounds] for the fight. Too much. People saying, ‘Oooh, isn’t he pretty?’ But I was too weak, didn’t feel like dancing. I was dazed. I was in a dream.”1

Any rheumatologist can figure out that Ali had developed a myopathy from the excess thyroid medication he took to trim down for the fight. Ali’s difficulty speaking persisted even after he stopped the thyroid medication, probably a precursor to the Parkinson’s disease that has plagued his later life.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A Boost by Any Other Name

Ali’s use of what he saw as a performance-enhancing drug received no opprobrium (maybe because he lost and the drug likely contributed to his loss). More recent attempts at enhancing athletic performances pharmacologically have been more successful but have led to disqualification. The disruption of the 2006 Tour de France, stripping of Floyd Landis’ victory in the Tour, the controversy over Barry Bonds’ home-run record, and Marion Jones’ admissions on the use of steroids have all made us more aware of the role of drugs in sports.

Performance-enhancing drugs are seen as cheating, a disgraceful shortcut to strength or endurance. A list of banned substances compiled by the bodies that regulate sports includes a variety of stimulants, anabolic steroids, b-adrenergic agents, diuretics, and hormones. But it must be obvious that many of the agents that athletes take offer no less of a boost. The best example of a permissible performance-enhancing substance is Gatorade, a sports drink concocted by researchers at the University of Florida to more rapidly replace the energy, fluid, and electrolytes lost by the Florida Gators football team (hence the name Gatorade) while playing in a swamp in full gear.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The fact that Gatorade enhances athletic performances is a point of pride to the makers of the drink. According to their Web site, “Soon after the researchers introduced their Gatorade formula to the team, the Gators began winning … outlasting a number of heavily favored opponents in the withering heat and finishing the season at 7–4. It was their first winning season in more than a decade.”

Page: 1 2 3 | Single Page
Share: 

Filed under:EthicsLegal UpdatesProfessional Topics Tagged with:DrugsPerformance-enhancing drugsSports

Related Articles
    Treating Rheumatologic Illnesses in Athletes

    Treating Rheumatologic Illnesses in Athletes

    May 13, 2016

    Never underestimate the power of dreams and the influence of the human spirit. … The potential for greatness lives within each of us. —Wilma Rudolph, U.S. Olympic sprinter & winner of three gold medals From Spinnaker to Wheelchair It can be an unnerving experience when the patient you are about to see is young and…

    Is the Toll Sports Take on Athletes’ Bodies Worth Glory on the Gridiron?

    December 1, 2010

    Sports fans find enormous pleasure in arguing about topics such as the greatest player in baseball, the best heavyweight boxer, or the worst draft pick in the NFL. Most of these arguments cannot be resolved and ultimately do not matter. Nevertheless, the diehards joust with vehemence and passion, especially if fueled by some alcoholic brew….

    A Sporting Chance

    January 1, 2009

    Injury prevention and management in young athletes can arrest long-term harm

    Legal Updates: As Opioids for Pain Treatment Come Under Greater Scrutiny, Controlled Substance Agreements Matter More

    March 1, 2013

    These contracts can communicate a physician’s expectations for a pain treatment plan and guidelines for safe use by their patients

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences